Professor | Tang Shixing | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Tang Shixing
Contact Information	tamgshixing@smu.edu.cn
Language ability	Chinese, English
Province	Guangdong

Upload Avatar (500 x 500)

Name

Tang Shixing

Contact Information

tamgshixing@smu.edu.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Southern Medical University
Faculty	Public Health
Academic Background & Achievements	PhD: Not mentioned Achievement: Not mentioned
Awards	Zhejiang Province Thousand Talents Program Distinguished Expert (2015): Zhejiang Provincial Government Guangdong Province Leading Talent (2012): Guangdong Provincial Government FDA Outstanding Analytical Science Award (2011): U.S. Food and Drug Administration FDA Outstanding Achievement Award (2007): U.S. Food and Drug Administration NIH Outstanding Researcher Award (2001): U.S. National Institutes of Health Second Prize for Military Science and Technology Progress (1996): People's Liberation Army of China

University/Lab Affiliation and Title

Southern Medical University

Faculty

Public Health

Academic Background & Achievements

PhD: Not mentioned
Achievement: Not mentioned

Awards

Zhejiang Province Thousand Talents Program Distinguished Expert (2015): Zhejiang Provincial Government
Guangdong Province Leading Talent (2012): Guangdong Provincial Government
FDA Outstanding Analytical Science Award (2011): U.S. Food and Drug Administration
FDA Outstanding Achievement Award (2007): U.S. Food and Drug Administration
NIH Outstanding Researcher Award (2001): U.S. National Institutes of Health
Second Prize for Military Science and Technology Progress (1996): People's Liberation Army of China

Areas of Focus	Molecular Epidemiology of Infectious Diseases Research and Application of New Detection Technologies
Publications	Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study, He X, Zeng B, Wang Y, Pang Y, Zhang M, Hu T, Liang Y, Kang M, Tang S., 2023 Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China: A Cohort Study, Kang M, Yi Y, Li Y, Sun L, Deng A, Hu T, Zhang J, Liu J, Cheng M, Xie S, Luo M, Jiang J, Jiang Y, Tang S, He J., 2022 Rapid detection and tracking of Omicron variant of SARS-CoV-2 using CRISPR-Cas12a-based assay, Liang Y, Lin H, Zou L, Deng X, Tang S., 2022 Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China, Cheng Z, Yan H, Li Q, Ablan SD, Kleinpeter A, Freed EO, Wu H, Dzakah EE, Zhao J, Han Z, Wang H, Tang S., 2022 RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature, Chen S, Wu J, Yang X, Sun Q, Liu S, Rashid F, Dzakah EE, Wang H, Wang J, Gong P, Tang S., 2022 Chlamydia trachomatis Stimulation Enhances HIV-1 Susceptibility through the Modulation of a Member of the Macrophage Inflammatory Proteins, Dzakah EE, Zhao J, Wang L, Rashid F, Xu R, Yang L, Wan Z, Huang L, Wang H, Chen S, Ke W, Kyei F, Deng K, Tang S., 2021 Acquisition and transmission of HIV-1 among migrants and Chinese in Guangzhou, China from 2008 to 2012: Phylogenetic analysis of surveillance data, Yan H, Wu H, Xia Y, Huang L, Liang Y, Li Q, Chen L, Han Z, Tang S., 2021 Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication, Wan Z, Liu J, Hu F, Shui J, Li L, Wang H, Tang X, Hu C, Liang Y, Zhou Y, Cai W, Tang S., 2020 A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection, Wang H, Wan Z, Xu R, Guan Y, Zhu N, Li J, Xie Z, Lu A, Zhang F, Fu Y, Tang S., 2018 Second Human Pegivirus in Hepatitis C Virus-Infected and Hepatitis C Virus/HIV-1-Co-infected Persons Who Inject Drugs, China, Wang H, Wan Z, Sun Q, Wu Y, Li X, An X, Deng S, Zhu N, Ren X, Tong Y, Tang S., 2018

Areas of Focus

Molecular Epidemiology of Infectious Diseases
Research and Application of New Detection Technologies

Publications

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study, He X, Zeng B, Wang Y, Pang Y, Zhang M, Hu T, Liang Y, Kang M, Tang S., 2023
Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China: A Cohort Study, Kang M, Yi Y, Li Y, Sun L, Deng A, Hu T, Zhang J, Liu J, Cheng M, Xie S, Luo M, Jiang J, Jiang Y, Tang S, He J., 2022
Rapid detection and tracking of Omicron variant of SARS-CoV-2 using CRISPR-Cas12a-based assay, Liang Y, Lin H, Zou L, Deng X, Tang S., 2022
Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China, Cheng Z, Yan H, Li Q, Ablan SD, Kleinpeter A, Freed EO, Wu H, Dzakah EE, Zhao J, Han Z, Wang H, Tang S., 2022
RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature, Chen S, Wu J, Yang X, Sun Q, Liu S, Rashid F, Dzakah EE, Wang H, Wang J, Gong P, Tang S., 2022
Chlamydia trachomatis Stimulation Enhances HIV-1 Susceptibility through the Modulation of a Member of the Macrophage Inflammatory Proteins, Dzakah EE, Zhao J, Wang L, Rashid F, Xu R, Yang L, Wan Z, Huang L, Wang H, Chen S, Ke W, Kyei F, Deng K, Tang S., 2021
Acquisition and transmission of HIV-1 among migrants and Chinese in Guangzhou, China from 2008 to 2012: Phylogenetic analysis of surveillance data, Yan H, Wu H, Xia Y, Huang L, Liang Y, Li Q, Chen L, Han Z, Tang S., 2021
Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication, Wan Z, Liu J, Hu F, Shui J, Li L, Wang H, Tang X, Hu C, Liang Y, Zhou Y, Cai W, Tang S., 2020
A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection, Wang H, Wan Z, Xu R, Guan Y, Zhu N, Li J, Xie Z, Lu A, Zhang F, Fu Y, Tang S., 2018
Second Human Pegivirus in Hepatitis C Virus-Infected and Hepatitis C Virus/HIV-1-Co-infected Persons Who Inject Drugs, China, Wang H, Wan Z, Sun Q, Wu Y, Li X, An X, Deng S, Zhu N, Ren X, Tong Y, Tang S., 2018

Infectious Diseases Molecular Epidemiology Detection Technologies Hiv Hcv Sars-Cov-2 Crispr Diagnostics Public Health Epidemiology

Yu Xuejie - Wuhan University

Ma Lu - Wuhan University

Jiang Qi - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us